search
Back to results

A Comparison Between Ivor-Lewis and McKeown Minimally Invasive Esophagectomy

Primary Purpose

Esophageal Cancer

Status
Recruiting
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
MIE Ivor- Lewis
MIE McKeown
Sponsored by
The Second Hospital of Shandong University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Esophageal Cancer focused on measuring Thoracoscopic, laparoscopic, esophagectomy

Eligibility Criteria

30 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

(I) Patients with clinically staged T1-3N0-2M0 tumors; good cardiopulmonary function;

(II) Patients with lower thoracic esophageal tumors and esophageal- gastric junction tumor;

(III) Patients without a previous history of cancer;

(IV) Patients without a previous history of neck or chest surgery;

Exclusion Criteria:

(I) cardiopulmonary function not good enough for surgery;

(II) Patients with hybrid MIE

Sites / Locations

  • Yunpeng ZhaoRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Ivor-Lewis group

McKeown group

Arm Description

minimally invasive esophagectomy (MIE) with intrathoracic anastomosis

minimally invasive esophagectomy (MIE) with cervical anastomosis

Outcomes

Primary Outcome Measures

Operating time
Operating time in minutes
Blood loss
Blood loss in milliliter
Lymph nodes harvested
Lymph nodes harvested in number
Pulmonary complication
Pulmonary complication in rate
Anastomotic leakage
Anastomotic leakage in rate
Anastomotic stenosis
Anastomotic stenosis in rate
recurrent laryngeal nerve injury
recurrent laryngeal nerve injury in rate
Chylothorax
Chylothorax in rate
Cardiac arrhythmia
Cardiac arrhythmia in rate
Hospital stay
Hospital stay in days
mortality
mortality in rate

Secondary Outcome Measures

progression-free survival
progression-free survival in rate
overall survival
overall survival in rate

Full Information

First Posted
January 1, 2020
Last Updated
November 14, 2022
Sponsor
The Second Hospital of Shandong University
search

1. Study Identification

Unique Protocol Identification Number
NCT04217239
Brief Title
A Comparison Between Ivor-Lewis and McKeown Minimally Invasive Esophagectomy
Official Title
A Comparison of Short-term and Long- Term Outcomes Between Ivor-Lewis and McKeown Minimally Invasive Esophagectomy
Study Type
Interventional

2. Study Status

Record Verification Date
November 2022
Overall Recruitment Status
Recruiting
Study Start Date
January 1, 2020 (Actual)
Primary Completion Date
December 31, 2023 (Anticipated)
Study Completion Date
December 31, 2028 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
The Second Hospital of Shandong University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Surgery is still the main treatment for esophageal cancer, however, the complication and mortality rate of open esophagectomy is high. As a result, the thoracoscopic- laparoscopic minimally invasive esophagectomy (MIE) was developed. The MIE mainly comprised two surgical approaches: MIE McKeown approach (cervical anastomosis) and MIE Ivor-Lewis approach (intrathoracicanastomosis). The MIE with intrathoracic anastomosis (Ivor-Lewis) is increasingly used for the treatment of mid and lower esophageal cancers. Our study is trying to compare the safety, feasibility, and short-term and long- term outcomes between MIE Ivor-Lewis approach and MIE McKeown approach for the treatment of lower thoracic esophageal cancer and esophageal- gastric junction.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Esophageal Cancer
Keywords
Thoracoscopic, laparoscopic, esophagectomy

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
InvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
200 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Ivor-Lewis group
Arm Type
Experimental
Arm Description
minimally invasive esophagectomy (MIE) with intrathoracic anastomosis
Arm Title
McKeown group
Arm Type
Active Comparator
Arm Description
minimally invasive esophagectomy (MIE) with cervical anastomosis
Intervention Type
Procedure
Intervention Name(s)
MIE Ivor- Lewis
Intervention Description
minimally invasive esophagectomy (MIE) with intrathoracic anastomosis
Intervention Type
Procedure
Intervention Name(s)
MIE McKeown
Intervention Description
minimally invasive esophagectomy (MIE) with cervical anastomosis
Primary Outcome Measure Information:
Title
Operating time
Description
Operating time in minutes
Time Frame
1 day
Title
Blood loss
Description
Blood loss in milliliter
Time Frame
1 day
Title
Lymph nodes harvested
Description
Lymph nodes harvested in number
Time Frame
1 day
Title
Pulmonary complication
Description
Pulmonary complication in rate
Time Frame
1 month
Title
Anastomotic leakage
Description
Anastomotic leakage in rate
Time Frame
within one month
Title
Anastomotic stenosis
Description
Anastomotic stenosis in rate
Time Frame
within three months
Title
recurrent laryngeal nerve injury
Description
recurrent laryngeal nerve injury in rate
Time Frame
within three months
Title
Chylothorax
Description
Chylothorax in rate
Time Frame
within one month
Title
Cardiac arrhythmia
Description
Cardiac arrhythmia in rate
Time Frame
within one month
Title
Hospital stay
Description
Hospital stay in days
Time Frame
within 60 days
Title
mortality
Description
mortality in rate
Time Frame
within 90 days
Secondary Outcome Measure Information:
Title
progression-free survival
Description
progression-free survival in rate
Time Frame
within 5 years
Title
overall survival
Description
overall survival in rate
Time Frame
within 5 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
30 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: (I) Patients with clinically staged T1-3N0-2M0 tumors; good cardiopulmonary function; (II) Patients with lower thoracic esophageal tumors and esophageal- gastric junction tumor; (III) Patients without a previous history of cancer; (IV) Patients without a previous history of neck or chest surgery; Exclusion Criteria: (I) cardiopulmonary function not good enough for surgery; (II) Patients with hybrid MIE
Facility Information:
Facility Name
Yunpeng Zhao
City
Jinan
State/Province
Shandong
ZIP/Postal Code
250033
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yunpeng Zhao
Phone
+8618766188692
Email
zyp_baggio@163.com

12. IPD Sharing Statement

Citations:
PubMed Identifier
34758861
Citation
Zhao Y, Shan L, Peng C, Cong B, Zhao X. Learning curve for minimally invasive oesophagectomy of oesophageal cancer and survival analysis. J Cardiothorac Surg. 2021 Nov 10;16(1):328. doi: 10.1186/s13019-021-01712-7.
Results Reference
derived

Learn more about this trial

A Comparison Between Ivor-Lewis and McKeown Minimally Invasive Esophagectomy

We'll reach out to this number within 24 hrs